240 related articles for article (PubMed ID: 22665574)
21. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages.
Tachibana M; Tenno M; Tezuka C; Sugiyama M; Yoshida H; Taniuchi I
J Immunol; 2011 Feb; 186(3):1450-7. PubMed ID: 21178013
[TBL] [Abstract][Full Text] [Related]
22. C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.
Barberi T; Cui C; Friedman AD
PLoS One; 2020; 15(12):e0244161. PubMed ID: 33332417
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional repression of Gata3 is essential for early B cell commitment.
Banerjee A; Northrup D; Boukarabila H; Jacobsen SE; Allman D
Immunity; 2013 May; 38(5):930-42. PubMed ID: 23684985
[TBL] [Abstract][Full Text] [Related]
24. Extrinsic and intrinsic signals converge on the Runx1/CBFβ transcription factor for nonpeptidergic nociceptor maturation.
Huang S; O'Donovan KJ; Turner EE; Zhong J; Ginty DD
Elife; 2015 Sep; 4():e10874. PubMed ID: 26418744
[TBL] [Abstract][Full Text] [Related]
25. RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
Gunnell A; Webb HM; Wood CD; McClellan MJ; Wichaidit B; Kempkes B; Jenner RG; Osborne C; Farrell PJ; West MJ
Nucleic Acids Res; 2016 Jun; 44(10):4636-50. PubMed ID: 26883634
[TBL] [Abstract][Full Text] [Related]
26. Expression pattern of Runt-related transcription factor (RUNX) family members and the role of RUNX1 during kidney development.
Yano-Sakamoto K; Kitai Y; Toriu N; Yamamoto S; Mizuta K; Saitou M; Tsukiyama T; Taniuchi I; Osato M; Yanagita M
Biochem Biophys Res Commun; 2024 Aug; 722():150155. PubMed ID: 38795454
[TBL] [Abstract][Full Text] [Related]
27. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
[TBL] [Abstract][Full Text] [Related]
28. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
[TBL] [Abstract][Full Text] [Related]
29. Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.
Illendula A; Gilmour J; Grembecka J; Tirumala VSS; Boulton A; Kuntimaddi A; Schmidt C; Wang L; Pulikkan JA; Zong H; Parlak M; Kuscu C; Pickin A; Zhou Y; Gao Y; Mishra L; Adli M; Castilla LH; Rajewski RA; Janes KA; Guzman ML; Bonifer C; Bushweller JH
EBioMedicine; 2016 Jun; 8():117-131. PubMed ID: 27428424
[TBL] [Abstract][Full Text] [Related]
30. The RUNX Transcriptional Coregulator, CBFβ, Suppresses Migration of ER
Pegg HJ; Harrison H; Rogerson C; Shore P
Mol Cancer Res; 2019 May; 17(5):1015-1023. PubMed ID: 30655324
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.
Brady G; Whiteman HJ; Spender LC; Farrell PJ
J Virol; 2009 Jul; 83(13):6909-16. PubMed ID: 19403666
[TBL] [Abstract][Full Text] [Related]
32. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
33. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
34. Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1.
Wu F; Song T; Yao Y; Song Y
PLoS One; 2019; 14(5):e0216203. PubMed ID: 31048839
[TBL] [Abstract][Full Text] [Related]
35. Cbfbeta-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development.
Kuo YH; Gerstein RM; Castilla LH
Blood; 2008 Feb; 111(3):1543-51. PubMed ID: 17940206
[TBL] [Abstract][Full Text] [Related]
36. Deletion of core-binding factor β (Cbfβ) in mesenchymal progenitor cells provides new insights into Cbfβ/Runxs complex function in cartilage and bone development.
Wu M; Li C; Zhu G; Wang Y; Jules J; Lu Y; McConnell M; Wang YJ; Shao JZ; Li YP; Chen W
Bone; 2014 Aug; 65():49-59. PubMed ID: 24798493
[TBL] [Abstract][Full Text] [Related]
37. Core-binding factor β and Runx transcription factors promote adaptive natural killer cell responses.
Rapp M; Lau CM; Adams NM; Weizman OE; O'Sullivan TE; Geary CD; Sun JC
Sci Immunol; 2017 Dec; 2(18):. PubMed ID: 29222089
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of cooperative binding of transcription factors Runx1-CBFβ-Ets1 on the TCRα gene enhancer.
Kasahara K; Shiina M; Fukuda I; Ogata K; Nakamura H
PLoS One; 2017; 12(2):e0172654. PubMed ID: 28231333
[TBL] [Abstract][Full Text] [Related]
39. MAZR and Runx Factors Synergistically Repress ThPOK during CD8+ T Cell Lineage Development.
Sakaguchi S; Hainberger D; Tizian C; Tanaka H; Okuda T; Taniuchi I; Ellmeier W
J Immunol; 2015 Sep; 195(6):2879-87. PubMed ID: 26254341
[TBL] [Abstract][Full Text] [Related]
40. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5.
Roessler S; Györy I; Imhof S; Spivakov M; Williams RR; Busslinger M; Fisher AG; Grosschedl R
Mol Cell Biol; 2007 Jan; 27(2):579-94. PubMed ID: 17101802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
